Omega-3 Fats Feed the Human Brain, Not the Hips

Omega-3 Fats Feed the Human Brain, Not the Hips Research reported in December PUFA Newsletter suggests that ocosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) feed the human brain and may improve psychiatric conditions as well as visual function.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Improved Mood Connected to Anti-Inflammatory Properties of Tibetan PADMA Formula performed at Austria's Innsbruck Medical University, examines earlier clinical research of PADMA's effects on intermittent claudication - study finds that participants reported feelings of increased well-being after taking PADMA and point to a possible mechanism that explains the previously reported mood changes in association with PADMA treatment. Improved Mood Connected to Anti-Inflammatory Properties of Tibetan PADMA Formula performed at Austria's Innsbruck Medical University, examines earlier clinical research of PADMA's effects on intermittent claudication - study finds that participants reported feelings of increased well-being after taking PADMA and point to a possible mechanism that explains the previously reported mood changes in association with PADMA treatment. Improved Mood Connected to Anti-Inflammatory Properties of Tibetan PADMA Formula performed at Austria's Innsbruck Medical University, examines earlier clinical research of PADMA's effects on intermittent claudication - study finds that participants reported feelings of increased well-being after taking PADMA and point to a possible mechanism that explains the previously reported mood changes in association with PADMA treatment. Improved Mood Connected to Anti-Inflammatory Properties of Tibetan PADMA Formula performed at Austria's Innsbruck Medical University, examines earlier clinical research of PADMA's effects on intermittent claudication - study finds that participants reported feelings of increased well-being after taking PADMA and point to a possible mechanism that explains the previously reported mood changes in association with PADMA treatment. Improved Mood Connected to Anti-Inflammatory Properties of Tibetan PADMA Formula performed at Austria's Innsbruck Medical University, examines earlier clinical research of PADMA's effects on intermittent claudication - study finds that participants reported feelings of increased well-being after taking PADMA and point to a possible mechanism that explains the previously reported mood changes in association with PADMA treatment. Small Study Shows SAMe May Improve Treatment of Depression Researchers at Massachusetts General Hospital have found that adding SAMe to a standard antidepressant may be helpful to patients who have not responded to single-drug treatment for clinical depression. Small Study Shows SAMe May Improve Treatment of Depression Researchers at Massachusetts General Hospital have found that adding SAMe to a standard antidepressant may be helpful to patients who have not responded to single-drug treatment for clinical depression. Small Study Shows SAMe May Improve Treatment of Depression Researchers at Massachusetts General Hospital have found that adding SAMe to a standard antidepressant may be helpful to patients who have not responded to single-drug treatment for clinical depression. Small Study Shows SAMe May Improve Treatment of Depression Researchers at Massachusetts General Hospital have found that adding SAMe to a standard antidepressant may be helpful to patients who have not responded to single-drug treatment for clinical depression. Small Study Shows SAMe May Improve Treatment of Depression Researchers at Massachusetts General Hospital have found that adding SAMe to a standard antidepressant may be helpful to patients who have not responded to single-drug treatment for clinical depression. Initial Results Reported in Clinical Study of Herbal Product Honso® Sho-saiko-to (H09) Japanese herbal product, Sho-saiko-to (H09), is under a clinical phase II trial by Memorial Sloan-Kettering Cancer Center to determine its effect on hepatitis C patients; preliminary results reported. Initial Results Reported in Clinical Study of Herbal Product Honso® Sho-saiko-to (H09) Japanese herbal product, Sho-saiko-to (H09), is under a clinical phase II trial by Memorial Sloan-Kettering Cancer Center to determine its effect on hepatitis C patients; preliminary results reported. Initial Results Reported in Clinical Study of Herbal Product Honso® Sho-saiko-to (H09) Japanese herbal product, Sho-saiko-to (H09), is under a clinical phase II trial by Memorial Sloan-Kettering Cancer Center to determine its effect on hepatitis C patients; preliminary results reported. Initial Results Reported in Clinical Study of Herbal Product Honso® Sho-saiko-to (H09) Japanese herbal product, Sho-saiko-to (H09), is under a clinical phase II trial by Memorial Sloan-Kettering Cancer Center to determine its effect on hepatitis C patients; preliminary results reported. VERIS Research: Monthly Research Update On Antioxidants, Botanicals, and Other Nutrients. Phytosterols Continue to Show Promise in Reducing Cholesterol Levels; Vitamin E Supplements May Reduce Patients' Tendency Toward Blood Clots; Vitamins E and C Block Gene Involved in Prostate Cancer in a Cell Study; Beta-Carotene May Help Prevent Allergies; Mouse Study Suggests that Alpha-Lipoic Acid May Be Beneficial in Asthma; St. John's Wort May Help Patients with Difficult-to-Diagnose Psychological Disorders; VERIS Research: Monthly Research Update On Antioxidants, Botanicals, and Other Nutrients. Phytosterols Continue to Show Promise in Reducing Cholesterol Levels; Vitamin E Supplements May Reduce Patients' Tendency Toward Blood Clots; Vitamins E and C Block Gene Involved in Prostate Cancer in a Cell Study; Beta-Carotene May Help Prevent Allergies; Mouse Study Suggests that Alpha-Lipoic Acid May Be Beneficial in Asthma; St. John's Wort May Help Patients with Difficult-to-Diagnose Psychological Disorders; VERIS Research: Monthly Research Update On Antioxidants, Botanicals, and Other Nutrients. Phytosterols Continue to Show Promise in Reducing Cholesterol Levels; Vitamin E Supplements May Reduce Patients' Tendency Toward Blood Clots; Vitamins E and C Block Gene Involved in Prostate Cancer in a Cell Study; Beta-Carotene May Help Prevent Allergies; Mouse Study Suggests that Alpha-Lipoic Acid May Be Beneficial in Asthma; St. John's Wort May Help Patients with Difficult-to-Diagnose Psychological Disorders; VERIS Research: Monthly Research Update On Antioxidants, Botanicals, and Other Nutrients. Phytosterols Continue to Show Promise in Reducing Cholesterol Levels; Vitamin E Supplements May Reduce Patients' Tendency Toward Blood Clots; Vitamins E and C Block Gene Involved in Prostate Cancer in a Cell Study; Beta-Carotene May Help Prevent Allergies; Mouse Study Suggests that Alpha-Lipoic Acid May Be Beneficial in Asthma; St. John's Wort May Help Patients with Difficult-to-Diagnose Psychological Disorders; VERIS Research: Monthly Research Update On Antioxidants, Botanicals, and Other Nutrients. Phytosterols Continue to Show Promise in Reducing Cholesterol Levels; Vitamin E Supplements May Reduce Patients' Tendency Toward Blood Clots; Vitamins E and C Block Gene Involved in Prostate Cancer in a Cell Study; Beta-Carotene May Help Prevent Allergies; Mouse Study Suggests that Alpha-Lipoic Acid May Be Beneficial in Asthma; St. John's Wort May Help Patients with Difficult-to-Diagnose Psychological Disorders; VERIS Research: Monthly Research Update On Antioxidants, Botanicals, and Other Nutrients. Phytosterols Continue to Show Promise in Reducing Cholesterol Levels; Vitamin E Supplements May Reduce Patients' Tendency Toward Blood Clots; Vitamins E and C Block Gene Involved in Prostate Cancer in a Cell Study; Beta-Carotene May Help Prevent Allergies; Mouse Study Suggests that Alpha-Lipoic Acid May Be Beneficial in Asthma; St. John's Wort May Help Patients with Difficult-to-Diagnose Psychological Disorders; New Study Highlights Benefits of Calcilife(TM) on Calcium Absorption and Retention and Bone Mineral Density Study conducted by the School of Human Ecology at Louisiana State University, evaluated the effects of CalciLife on mineral absorption and retention, bone mineral content and bone mineral density in an animal population. New Study Highlights Benefits of Calcilife(TM) on Calcium Absorption and Retention and Bone Mineral Density Study conducted by the School of Human Ecology at Louisiana State University, evaluated the effects of CalciLife on mineral absorption and retention, bone mineral content and bone mineral density in an animal population. New Study Highlights Benefits of Calcilife(TM) on Calcium Absorption and Retention and Bone Mineral Density Study conducted by the School of Human Ecology at Louisiana State University, evaluated the effects of CalciLife on mineral absorption and retention, bone mineral content and bone mineral density in an animal population. New Study Highlights Benefits of Calcilife(TM) on Calcium Absorption and Retention and Bone Mineral Density Study conducted by the School of Human Ecology at Louisiana State University, evaluated the effects of CalciLife on mineral absorption and retention, bone mineral content and bone mineral density in an animal population. New Study Highlights Benefits of Calcilife(TM) on Calcium Absorption and Retention and Bone Mineral Density Study conducted by the School of Human Ecology at Louisiana State University, evaluated the effects of CalciLife on mineral absorption and retention, bone mineral content and bone mineral density in an animal population. New Study Highlights Benefits of Calcilife(TM) on Calcium Absorption and Retention and Bone Mineral Density Study conducted by the School of Human Ecology at Louisiana State University, evaluated the effects of CalciLife on mineral absorption and retention, bone mineral content and bone mineral density in an animal population. Vitamin E May Offer Protection Against the Risk of Developing ALS Researchers from the Harvard School of Public Health and the American Cancer Society have found that vitamin E may play an important role in the prevention of the devastating motor neuron disease ALS (amyotrophic lateral sclerosis). Vitamin E May Offer Protection Against the Risk of Developing ALS Researchers from the Harvard School of Public Health and the American Cancer Society have found that vitamin E may play an important role in the prevention of the devastating motor neuron disease ALS (amyotrophic lateral sclerosis). Vitamin E May Offer Protection Against the Risk of Developing ALS Researchers from the Harvard School of Public Health and the American Cancer Society have found that vitamin E may play an important role in the prevention of the devastating motor neuron disease ALS (amyotrophic lateral sclerosis). Vitamin E May Offer Protection Against the Risk of Developing ALS Researchers from the Harvard School of Public Health and the American Cancer Society have found that vitamin E may play an important role in the prevention of the devastating motor neuron disease ALS (amyotrophic lateral sclerosis). Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000. Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000. Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000. Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000. Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000. Study Examines Relationship of Vitamin A Pathway to Breast Tumor Progression Study suggests that defects in vitamin A bioactivity may be a possible contributor to human carcinogenesis since vitamin A is required for activation of the retinoic acid receptor (RAR), which induces differentiation of adult epithelial cells. Study Examines Relationship of Vitamin A Pathway to Breast Tumor Progression Study suggests that defects in vitamin A bioactivity may be a possible contributor to human carcinogenesis since vitamin A is required for activation of the retinoic acid receptor (RAR), which induces differentiation of adult epithelial cells. Study Examines Relationship of Vitamin A Pathway to Breast Tumor Progression Study suggests that defects in vitamin A bioactivity may be a possible contributor to human carcinogenesis since vitamin A is required for activation of the retinoic acid receptor (RAR), which induces differentiation of adult epithelial cells. Study Examines Relationship of Vitamin A Pathway to Breast Tumor Progression Study suggests that defects in vitamin A bioactivity may be a possible contributor to human carcinogenesis since vitamin A is required for activation of the retinoic acid receptor (RAR), which induces differentiation of adult epithelial cells. Lycopene Supplements Found to Reduce Cancer-Causing Cell Count Study published in the Fall issue of Journal of Medicinal Food demonstrated that lycopene supplements decreased the proliferation of cancer cells at certain intervals of the study. Lycopene Supplements Found to Reduce Cancer-Causing Cell Count Study published in the Fall issue of Journal of Medicinal Food demonstrated that lycopene supplements decreased the proliferation of cancer cells at certain intervals of the study. Lycopene Supplements Found to Reduce Cancer-Causing Cell Count Study published in the Fall issue of Journal of Medicinal Food demonstrated that lycopene supplements decreased the proliferation of cancer cells at certain intervals of the study. Lycopene Supplements Found to Reduce Cancer-Causing Cell Count Study published in the Fall issue of Journal of Medicinal Food demonstrated that lycopene supplements decreased the proliferation of cancer cells at certain intervals of the study. Lycopene Supplements Found to Reduce Cancer-Causing Cell Count Study published in the Fall issue of Journal of Medicinal Food demonstrated that lycopene supplements decreased the proliferation of cancer cells at certain intervals of the study. Lycopene Supplements Found to Reduce Cancer-Causing Cell Count Study published in the Fall issue of Journal of Medicinal Food demonstrated that lycopene supplements decreased the proliferation of cancer cells at certain intervals of the study. Lycopene Supplements Found to Reduce Cancer-Causing Cell Count Study published in the Fall issue of Journal of Medicinal Food demonstrated that lycopene supplements decreased the proliferation of cancer cells at certain intervals of the study. Study Concludes DHA Restores Blood Vessel Function in Children With High Cholesterol Study published in the December issue of The International Journal of Clinical Pharmacology and Therapeutics concludes that DHA restores normal blood vessel function in children with inherited high cholesterol. Study Concludes DHA Restores Blood Vessel Function in Children With High Cholesterol Study published in the December issue of The International Journal of Clinical Pharmacology and Therapeutics concludes that DHA restores normal blood vessel function in children with inherited high cholesterol. Study Concludes DHA Restores Blood Vessel Function in Children With High Cholesterol Study published in the December issue of The International Journal of Clinical Pharmacology and Therapeutics concludes that DHA restores normal blood vessel function in children with inherited high cholesterol. Study Concludes DHA Restores Blood Vessel Function in Children With High Cholesterol Study published in the December issue of The International Journal of Clinical Pharmacology and Therapeutics concludes that DHA restores normal blood vessel function in children with inherited high cholesterol. Study Concludes DHA Restores Blood Vessel Function in Children With High Cholesterol Study published in the December issue of The International Journal of Clinical Pharmacology and Therapeutics concludes that DHA restores normal blood vessel function in children with inherited high cholesterol. New Study Shows Benefits for Autism and Asperger’s Syndrome With Essential Fatty Acid Supplementation Pilot trial, published in January/February 2005 issue of Autism-Asperger’s Digest, shows beneficial effects of essential fatty acids (EFAs) on language and learning skills in children with autism and Asperger’s syndrome. New Study Shows Benefits for Autism and Asperger’s Syndrome With Essential Fatty Acid Supplementation Pilot trial, published in January/February 2005 issue of Autism-Asperger’s Digest, shows beneficial effects of essential fatty acids (EFAs) on language and learning skills in children with autism and Asperger’s syndrome. New Study Shows Benefits for Autism and Asperger’s Syndrome With Essential Fatty Acid Supplementation Pilot trial, published in January/February 2005 issue of Autism-Asperger’s Digest, shows beneficial effects of essential fatty acids (EFAs) on language and learning skills in children with autism and Asperger’s syndrome. New Study Shows Benefits for Autism and Asperger’s Syndrome With Essential Fatty Acid Supplementation Pilot trial, published in January/February 2005 issue of Autism-Asperger’s Digest, shows beneficial effects of essential fatty acids (EFAs) on language and learning skills in children with autism and Asperger’s syndrome. New Study Shows Benefits for Autism and Asperger’s Syndrome With Essential Fatty Acid Supplementation Pilot trial, published in January/February 2005 issue of Autism-Asperger’s Digest, shows beneficial effects of essential fatty acids (EFAs) on language and learning skills in children with autism and Asperger’s syndrome. New Canadian Human Trial Supports Wide-scope CVD Benefits of CarDiabeat(TM) Initial results suggest that carDiabeatTM shows significantly better results on the body's total lipid profile in comparison to other supplements. New Canadian Human Trial Supports Wide-scope CVD Benefits of CarDiabeat(TM) Initial results suggest that carDiabeatTM shows significantly better results on the body's total lipid profile in comparison to other supplements. New Canadian Human Trial Supports Wide-scope CVD Benefits of CarDiabeat(TM) Initial results suggest that carDiabeatTM shows significantly better results on the body's total lipid profile in comparison to other supplements. New Canadian Human Trial Supports Wide-scope CVD Benefits of CarDiabeat(TM) Initial results suggest that carDiabeatTM shows significantly better results on the body's total lipid profile in comparison to other supplements. Pivotal Clinical Study on Performance of Stress Neutralizing Formula OCTA(TM) Produces Impressive Interim Results Interim results of clinical show promise. Pivotal Clinical Study on Performance of Stress Neutralizing Formula OCTA(TM) Produces Impressive Interim Results Interim results of clinical show promise. Pivotal Clinical Study on Performance of Stress Neutralizing Formula OCTA(TM) Produces Impressive Interim Results Interim results of clinical show promise. Pivotal Clinical Study on Performance of Stress Neutralizing Formula OCTA(TM) Produces Impressive Interim Results Interim results of clinical show promise. Diabetes Trial Measures Efficacy of Neuragen® Feedback survey shows that 69% of patients report lessening of pain associated with diabetic peripheral neuropathy (DPN). Diabetes Trial Measures Efficacy of Neuragen® Feedback survey shows that 69% of patients report lessening of pain associated with diabetic peripheral neuropathy (DPN). Diabetes Trial Measures Efficacy of Neuragen® Feedback survey shows that 69% of patients report lessening of pain associated with diabetic peripheral neuropathy (DPN). Diabetes Trial Measures Efficacy of Neuragen® Feedback survey shows that 69% of patients report lessening of pain associated with diabetic peripheral neuropathy (DPN). New Research on Pine Bark (Pycnogenol) and Childhood Asthma Study published in the November/December issue of Journal of Asthma shows decrease in asthma symptoms, use of rescue inhalers in mild to moderate asthmatics. New Research on Pine Bark (Pycnogenol) and Childhood Asthma Study published in the November/December issue of Journal of Asthma shows decrease in asthma symptoms, use of rescue inhalers in mild to moderate asthmatics. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	DENVER, Dec 28, 2004 -- Peer-reviewed research shows that long-chain omega-3 polyunsaturated fatty acids (n-3 LC-PUFAs) -- namely docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) -- feed the human brain and may improve psychiatric conditions as well as visual function. This research is described in the December 2004 PUFA Newsletter. A guest commentary on n-3 LC-PUFAs and the brain reveals that DHA helps cell membranes, intracellular metabolism, and regulation of gene expression. It also shows that DHA is key to brain metabolism and both DHA and EPA are beneficial in neuropsychiatric conditions. "Manic-depressive illness, depression, and schizophrenia are common neuropsychiatric disorders," writes Andrew Sinclair, Ph.D., professor of food science, RMIT University, Melbourne, Australia. "Results from case-control studies, clinical trials, and case studies have shown that oils rich in n-3 LC-PUFAs play a beneficial role in these neuropsychiatric conditions." Other studies show that DHA also plays a role in retinal cell signaling, and thus, helps optimize visual function. Vitamin A intake may enhance the beneficial effects of n-3 LC-PUFAs on eyesight. "A diet rich in fish omega-3s with vitamin A supplementation may retard premature visual loss in retinitis pigmentosa," notes Joyce Nettleton, D.Sc., R.D., editor, PUFA Newsletter. More new research shows that fish consumption in a calorie-restricted diet among overweight subjects with high blood pressure enhances the beneficial effects of weight loss. With both caloric restriction and daily fish consumption, reductions in blood pressure and improvements in fat profile, heart rate, and sugar metabolism are greater than with weight loss alone. "These benefits are also effective in simultaneously reducing the risk of stroke, cardiovascular disease and myocardial infarction," Nettleton says. Moreover, consumption of n-3 PUFAs may reduce allergic inflammation in airways, reducing the severity of asthma and improving the quality of life in children at high risk of developing asthma. Some day, n-3 LC-PUFAs, which are only naturally occurring in fish and algae, may be available from bioengineered oilseed plants. Scientists recently took another step in this direction by getting yeast and linseed to synthesize DHA with only low levels of unwanted by-products. Sponsored by DSM Nutritional Products, the quarterly PUFA Newsletter is available online at http://www.fatsoflife.com and by complimentary electronic subscription at http://www.fatsoflife.com/subscribe.asp .
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software